A hybrid arrowhead against immune disorders: Bacterially derived natural product inhibits cellular immune response
The illustration shows a syrbactine molecule covalently attached to the proteasome, inhibiting it. Through synthetic-biological modifications of the enzymes that produce syrbactin, the research team developed the first drug variants…